Phase I and pharmacokinetic study of the P-glycoprotein modulator dexniguldipine-HCL.

European journal of medical research

Volumn 2, Issue 2, 1997, Pages 55-61

  Nuessler, V ^a   Scheulen, M E ^a   Oberneder, R ^a   Kriegmair, M ^a   Goebel, K J ^a   Rathgeb, F ^a   Wurst, W ^a   Zech, K ^a   Wilmanns, W ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DIHYDROPYRIDINE DERIVATIVE; GLYCOPROTEIN P; NIGULDIPINE; VINBLASTINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; METASTASIS; MIDDLE AGED; MULTICENTER STUDY; NEOPLASM; PATHOLOGY; PHASE 1 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTINEOPLASTIC AGENTS; DIHYDROPYRIDINES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS; P-GLYCOPROTEIN; VINBLASTINE;

EID: 0031581672     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)